半岛bd体育手机客户端 说明
一般描述
The Transcreener?UDP2 TR-FRET Red Assay is a competitive immunoassay for UDP with a far-red, time-resolved F?rster-resonance-energy-transfer (TR-FRET) readout. Because it is highly selective for UDP, the assay can be used with any enzyme that generates UDP from a UDP-sugar donor. Examples include glycosyltransferase, galactosyltransferase, glucuronyltransferase, N-acetylglucosamyltransferase, N-acetylgalactosyltransferase, xylosyltransferase, and glycogen, cellulose, lactose, and hyaluronan synthases. The Transcreener?assay is designed specifically for high-throughput screening (HTS), with a single-addition, mix-and-read format. It offers reagent stability and compatibility with commonly used multimode plate readers. The generic nature of the Transcreener?HTS assay platform eliminates delays involved in assay development for new HTS targets and greatly simplifies compound and inhibitor profiling across multiple target families.
The Transcreener?UDP2 TR-FRET Red Assay provides the following benefits:
数量
3022-1K = 1,000 assay, 384-well
3022-10K = 10,000 assay, 384-well
外形
Kit with buffered aqueous solutions
法律信息
Transcreener is a registered trademark of BellBrook Labs
基本信息
NACRES | NA.84 |
半岛bd体育手机客户端 性质
运输 | dry ice |
储存温度 | ?20℃ |
Sigma-Aldrich